Skip to content

China SXT Pharmaceuticals, Inc.: 20-F filed 2020-07-31

What China SXT Pharmaceuticals, Inc. reported in its annual report (foreign private issuer) filed 2020-07-31 (fiscal FY 2020): 44 published measures, 114 facts as tagged in accession 0001213900-20-019503.

This filing

Form
20-F (annual report (foreign private issuer))
Filed
2020-07-31
Fiscal period
fiscal FY 2020
Accession
0001213900-20-019503 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All China SXT Pharmaceuticals, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-03-3121,702,178USD
At 2019-03-3117,470,833USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-03-3112,300,825USD
At 2019-03-316,363,078USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-03-319,401,353USD
At 2019-03-3111,107,755USD
At 2018-03-313,285,775USD
At 2017-03-311,852,646USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-03-317,287,032USD
At 2019-03-319,130,849USD
At 2018-03-31657,767USD
At 2017-03-3165,570USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-04-01 to 2020-03-31-10,287,872USD366
2018-04-01 to 2019-03-311,539,227USD365
2017-04-01 to 2018-03-311,187,581USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-04-01 to 2020-03-31934,247USD366
2018-04-01 to 2019-03-31239,192USD365
2017-04-01 to 2018-03-311,920,161USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2019-04-01 to 2020-03-31130,839USD366
2018-04-01 to 2019-03-31535,825USD365
2017-04-01 to 2018-03-31436,017USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2019-04-01 to 2020-03-315,162,268USD366
2018-04-01 to 2019-03-317,012,026USD365
2017-04-01 to 2018-03-317,019,243USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-04-01 to 2020-03-313,024,369USD366
2018-04-01 to 2019-03-319,042,083USD365
2017-04-01 to 2018-03-31-314,216USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-04-01 to 2020-03-31-5,496,704USD366
2018-04-01 to 2019-03-31-610,085USD365
2017-04-01 to 2018-03-31-1,050,725USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-03-31-7,204,000USD
At 2019-03-313,083,872USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2019-04-01 to 2020-03-31-101,722USD366
2018-04-01 to 2019-03-31252,232USD365
2017-04-01 to 2018-03-31440,103USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-03-311,574,602USD
At 2019-03-311,158,898USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-04-01 to 2020-03-31-1,341,117USD366
2018-04-01 to 2019-03-311,769,492USD365
2017-04-01 to 2018-03-311,632,266USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-03-3119,636,313USD
At 2019-03-3115,588,100USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2019-04-01 to 2020-03-313,348,790USD366
2018-04-01 to 2019-03-315,174USD365
2017-04-01 to 2018-03-31779USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-03-3112,264,314USD
At 2019-03-316,321,372USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-03-311,941,151USD
At 2019-03-311,685,419USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2020-03-3150,052USD
At 2019-03-3161,096USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2020-03-313,819,437USD
At 2019-03-314,180,559USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-04-01 to 2020-03-314,044,819USD366
2018-04-01 to 2019-03-312,842,043USD365
2017-04-01 to 2018-03-311,769,229USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2020-03-31892,767USD
At 2019-03-311,007,918USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2019-04-01 to 2020-03-312,703,702USD366
2018-04-01 to 2019-03-314,611,535USD365
2017-04-01 to 2018-03-313,401,495USD365

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2019-04-01 to 2020-03-312,458,566USD366
2018-04-01 to 2019-03-312,400,491USD365
2017-04-01 to 2018-03-313,617,748USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-03-3134,667,707shares
At 2019-03-3122,706,701shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-03-3117,161,346USD
At 2019-03-317,950,782USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2020-03-31-590,660USD
At 2019-03-3150,395USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2020-03-3136,511USD
At 2019-03-3141,706USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2020-03-312,599,608USD
At 2019-03-311,904,327USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2020-03-311,025,006USD
At 2019-03-31745,429USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2020-03-314,618,740USD
At 2019-03-31707,337USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2019-04-01 to 2020-03-31-10,928,927USD366
2018-04-01 to 2019-03-311,332,249USD365
2017-04-01 to 2018-03-311,433,129USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2019-04-01 to 2020-03-312,461,535USD366
2018-04-01 to 2019-03-311,236,546USD365
2017-04-01 to 2018-03-311,256,747USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2019-04-01 to 2020-03-31323,852USD366
2018-04-01 to 2019-03-31174,020USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2019-04-01 to 2020-03-31331,837USD366
2018-04-01 to 2019-03-31180,917USD365
2017-04-01 to 2018-03-31129,439USD365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2019-04-01 to 2020-03-317,985USD366
2018-04-01 to 2019-03-316,967USD365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2019-04-01 to 2020-03-31-73,771USD366
2018-04-01 to 2019-03-3127,141USD365
2017-04-01 to 2018-03-31-3,803USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2019-04-01 to 2020-03-31-9,048,477USD366
2018-04-01 to 2019-03-3121,967USD365
2017-04-01 to 2018-03-31-4,582USD365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2019-04-01 to 2020-03-31-101,722USD366
2018-04-01 to 2019-03-31-7,723USD365
2017-04-01 to 2018-03-31-5,851USD365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2019-04-01 to 2020-03-3110,363USD366
2018-04-01 to 2019-03-3151,760USD365
2017-04-01 to 2018-03-3122,359USD365

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2019-04-01 to 2020-03-31287,810USD366
2018-04-01 to 2019-03-311,489USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2019-04-01 to 2020-03-31-104,001USD366
2018-04-01 to 2019-03-311,811,078USD365
2017-04-01 to 2018-03-31-384,434USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2019-04-01 to 2020-03-31-39,707USD366
2018-04-01 to 2019-03-31-154,526USD365
2017-04-01 to 2018-03-31274,384USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2019-04-01 to 2020-03-31302,266USD366
2018-04-01 to 2019-03-31-567,313USD365
2017-04-01 to 2018-03-31966,573USD365

Inspect the source

Entity
China SXT Pharmaceuticals, Inc. / CIK 0001723980
Captured
2026-09-21T17:27:28.025Z
SEC response SHA-256
5d9b67895a776113ebb838d9f4e37ed9332236cdc6d97b3ceb041843d0247442

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001723980.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))